23 MARÇO 2020

Board approves the 2019 accounts

News Release

SALES € 1,481.8 MILLION (+9.6%), EBITDA € 544.0 MILLION (+9.0%). 2019 DIVIDEND € 1.00 (+8.7%).

  • Consolidated revenues € 1,481.8 million, +9.6%.
  • EBITDA (1) € 544.0 million, +9,0%.
  • Operating income € 465.3 million, +5.2%.
  • Net income € 368.9 million, +18.1%, includes an extraordinary tax benefit of € 27.0 million from the so‐called “patent box” agreed with the Italian tax authorities in December 2019. Excluding this benefit net income would have been € 341.9 million, +9.4%.
  • Net financial position (2): net debt of € 902.7 million.
  • Subsequent events: Isturisa® (osilodrostat) approved in EU in January 2020 for Cushing’s syndrome and in the USA in March 2020 for Cushing’s disease.
  • Dividend for 2019 € 1.00 per share, of which € 0.48 already paid.
  • Resignation of Chairman Mr Flemming Ørnskov and of the Board members Mr Søren Vestergaard‐Poulsen and Mr Francisco Javier de Jaime Guijarro, effective as from the next Shareholders' Meeting, due to increased professional commitments.
  • Appointment of the manager responsible for preparing the Company’s financial reports.
  • Annual Meeting of Shareholders convened for 29 April 2020, the sole convocation date.

 

Milan, 18 March 2020 – Recordati’s Board of Directors approved the consolidated financial statements for the year 2019 as well as Recordati S.p.A.’s accounts and the 2019 corporate governance and ownership report as required by art. 123bis of the Consolidated Law on Financial Intermediation.

The financial statements at, and for the year ended, 31 December 2019 and the aforesaid report as well as the reports issued by the independent and by the statutory Auditors will be made available, within the terms of the law, at the company’s head office and published on the company’s website and can also be viewed on the authorized storage system 1Info.

The Board of Directors also approved the consolidated non financial information disclosure, pursuant to Legislative Decree n. 254, dated 31 December 2019 which will be made available in the same manner. 

 

See full report here

 

 

RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.A.

Sede Legale
VIA M. CIVITALI, 1 20148 MILANO, ITALIA
TEL. (39) 0248787.1 FAX (39) 0240073747

CAPITALE SOCIALE € 26.140.644,50 i.v.
REG. IMP. MILANO, MONZA, BRIANZA e LODI 00748210150 CODICE FISCALE/P. IVA 00748210150
R.E.A. MILANO 401832

Società Soggetta all’attività di Direzione e Coordinamento di Rossini Luxembourg S.àr.l